Nicholas Terry

Nicholas Terry, MCTM, serves as an Executive Sales Professional specializing in Psychology at Supernus Pharmaceuticals, Inc. since March 2014, where notable achievements include the launch of three clinical therapies and consistent recognition for market share growth, notably for the ADHD medication Qelbree. Prior roles include Executive Sales Representative for Neurology, contributing to significant market share accomplishments with Trokendi XR and Oxtellar XR, and a National Business Markets Enterprise Account Manager at AT&T, managing substantial enterprise accounts and receiving multiple awards for customer service and sales performance. Nicholas holds a Master’s Degree in Clinical Translation Management from the University of St. Thomas and a Bachelor of Business Administration from The University of Texas at San Antonio.